Kapil Mehta MS, PhD

Dr. Mehta with more than 30 years of experience is an internationally recognized researcher for his scientific contributions. He is tenured Professor at a premier cancer institute- the University of Texas M. D. Anderson Cancer Center in Houston, Texas. Major area of research in his laboratory includes the use of liposomes as drug delivery system and understanding molecular mechanisms involved in inflammation-induced progression of cancer and other chronic diseases.

He has pioneered the identification of a novel inflammatory signaling pathway that promotes metastatic competence in epithelial cancer cells. Central to this pathway is aberrant expression of a stress-response gene (TGM2), whose expression is epigenetically regulated in multiple drug-resistant and metastatic tumors and is associated with poor disease outcome in cancer patients.